The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE)

[1]  Gustavo Tenorio,et al.  Tissue concentration changes of amino acids and biogenic amines in the central nervous system of mice with experimental autoimmune encephalomyelitis (EAE) , 2011, Neurochemistry International.

[2]  G. Juckel,et al.  Inflammation modulates anxiety in an animal model of multiple sclerosis , 2011, Behavioural Brain Research.

[3]  K. Thibault,et al.  Characterisation of sensory abnormalities observed in an animal model of multiple sclerosis: A behavioural and pharmacological study , 2011, European journal of pain.

[4]  P. Mcgeer,et al.  Astrocytes are GABAergic cells that modulate microglial activity , 2011, Glia.

[5]  Abraham Weizman,et al.  The Immunomodulatory Effect of the Antidepressant Sertraline in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis , 2010, Neuroimmunomodulation.

[6]  K. Aitchison,et al.  Gender differences in antidepressant drug response , 2010, International review of psychiatry.

[7]  E. Obuchowicz,et al.  Moclobemide exerts anti-inflammatory effect in lipopolysaccharide-activated primary mixed glial cell culture , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  S. Dursun,et al.  The antidepressant phenelzine protects neurons and astrocytes against formaldehyde‐induced toxicity , 2010, Journal of neurochemistry.

[9]  S. Dursun,et al.  Phenelzine: An Old Drug That May Hold Clues to The Development of New Neuroprotective Agents , 2010 .

[10]  D. Feinstein,et al.  Increasing CNS Noradrenaline Reduces EAE Severity , 2010, Journal of Neuroimmune Pharmacology.

[11]  Melissa Miranda,et al.  Inhibitory role for GABA in autoimmune inflammation , 2010, Proceedings of the National Academy of Sciences.

[12]  J. O'Donnell,et al.  Association of Changes in Norepinephrine and Serotonin Transporter Expression with the Long-Term Behavioral Effects of Antidepressant Drugs , 2009, Neuropsychopharmacology.

[13]  H. Hartung,et al.  The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines. , 2009, The international journal of neuropsychopharmacology.

[14]  Camille J. Olechowski,et al.  Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE) , 2009, PAIN®.

[15]  Shuting Lin,et al.  γ-Aminobutyric Acid Transporter 1 Negatively Regulates T Cell-Mediated Immune Responses and Ameliorates Autoimmune Inflammation in the CNS1 , 2008, The Journal of Immunology.

[16]  M. Levite.  Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. , 2008, Current opinion in pharmacology.

[17]  R. Dworkin,et al.  Pain associated with multiple sclerosis: Systematic review and proposed classification , 2008, PAIN®.

[18]  I. Lucki,et al.  Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments , 2008, Brain Research.

[19]  P. Wood,et al.  Phenelzine Causes an Increase in Brain Ornithine that is Prevented by Prior Monoamine Oxidase Inhibition , 2008, Neurochemical Research.

[20]  G. Baker,et al.  Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders? , 2007, Journal of psychiatry & neuroscience : JPN.

[21]  S. Gold,et al.  Stress and hypothalamic–pituitary–adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis—A review , 2007, Psychoneuroendocrinology.

[22]  A. Cameron,et al.  Propofol hemisuccinate suppression of experimental autoimmune encephalomyelitis , 2007, Autoimmunity.

[23]  D. Hampson,et al.  Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[24]  P. Wood,et al.  Aldehyde load in ischemia–reperfusion brain injury: Neuroprotection by neutralization of reactive aldehydes with phenelzine , 2006, Brain Research.

[25]  S. Cammisuli,et al.  Changes of neurotransmitter systems in chronic relapsing experimental allergic encephalomyelitis in rat brain and spinal cord. , 2006, Journal of neurochemistry.

[26]  K. Toyka,et al.  Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen‐specific interferon‐gamma production in mouse EAE , 2005, Clinical and experimental immunology.

[27]  L. Jacobson,et al.  Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression. , 2005, Endocrinology.

[28]  S. Sands,et al.  Effect of antidepressants on GABAB receptor function and subunit expression in rat hippocampus , 2004 .

[29]  S. David,et al.  Cytosolic Phospholipase A2 Plays a Key Role in the Pathogenesis of Multiple Sclerosis-like Disease , 2004, Neuron.

[30]  Y. Pollak,et al.  The EAE-associated behavioral syndrome I. Temporal correlation with inflammatory mediators , 2003, Journal of Neuroimmunology.

[31]  Y. Pollak,et al.  The EAE-associated behavioral syndrome II. Modulation by anti-inflammatory treatments , 2003, Journal of Neuroimmunology.

[32]  R. Thurman,et al.  Molecular evidence for a glycine-gated chloride channel in macrophages and leukocytes. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[33]  I. Goshen,et al.  Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of ‘depression due to multiple sclerosis’ , 2002, Brain, Behavior, and Immunity.

[34]  M. Hascöet,et al.  Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice. , 2002, Journal of psychiatry & neuroscience : JPN.

[35]  T. Paslawski,et al.  β‐phenylethylidenehydrazine, a novel inhibitor of GABA transaminase , 2001 .

[36]  I. Martin,et al.  Effects of the Antidepressant/Antipanic Drug Phenelzine on Alanine and Alanine Transaminase in Rat Brain , 2001, Cellular and Molecular Neurobiology.

[37]  A. Greenshaw,et al.  Common effects of chronically administered antipanic drugs on brainstem GABAA receptor subunit gene expression , 2001, Molecular Psychiatry.

[38]  R. Voskuhl,et al.  Sex Hormones in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis , 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[39]  T. Koyama,et al.  Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats. , 2000, European journal of pharmacology.

[40]  R. Whelpton,et al.  Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex—a possible mechanism of neuroprotection in major depression? , 2000, Neuroscience.

[41]  G. Baker,et al.  Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine. , 2000, Biochemical pharmacology.

[42]  I. Goshen,et al.  Behavioral aspects of experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.

[43]  E. Bosmans,et al.  The in vitro immunosuppressive effects of moclobemide in healthy volunteers. , 2000, Journal of affective disorders.

[44]  G. Perrault,et al.  Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine–oxidase activity and monoamine levels , 1998, Neuropharmacology.

[45]  J. Denburg,et al.  Neurobehavioral alterations in autoimmune mice , 1997, Neuroscience & Biobehavioral Reviews.

[46]  H. Szechtman,et al.  Review: Behaviour of MRL Mice: An Animal Model of Disturbed Behaviour in Systemic Autoimmune Disease , 1997, Lupus.

[47]  T. Paslawski,et al.  The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA , 1996, Psychopharmacology.

[48]  J. Denburg,et al.  Disturbed emotionality in autoimmune MRL-lpr mice , 1994, Physiology & Behavior.

[49]  D. McManus,et al.  Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain. , 1992, Biochemical pharmacology.

[50]  G. Baker,et al.  N2-Acetylphenelzine : effects on rat brain GABA, alanine and biogenic amines , 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

[51]  G. Baker,et al.  Effects of the antidepressant phenelzine on brain levels of γ-aminobutyric acid (GABA) , 1991 .

[52]  R. M. Bowker,et al.  Damage to bulbospinal serotonin‐, tyrosine hydroxylase‐, and TRH‐containing axons occurs early in the development of experimental allergic encephalomyelitis in rats , 1990, Journal of neuroscience research.

[53]  W. Krenger,et al.  Monoamines and related substances in brainstem and spinal cord of Lewis rats during the attack and recovery of experimental autoimmune encephalomyelitis , 1989, Brain Research.

[54]  C. de Montigny,et al.  Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system. , 1986, The Journal of pharmacology and experimental therapeutics.

[55]  D. Bieger,et al.  Serotonin immunoreactivity in spinal cord axons and terminals of rodents with experimental allergic encephalomyelitis , 1985, Neuroscience.

[56]  W. Dewhurst,et al.  Rat brain concentrations of 5-hydroxytryptamine following acute and chronic administration of MAO-inhibiting antidepressants , 1984, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[57]  W. Dewhurst,et al.  Regional concentrations of cerebral amines: effects of tranylcypromine and phenelzine , 1983, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[58]  N. Popov,et al.  SOME EFFECTS OF MONOAMINE OXIDASE INHIBITORS ON THE METABOLISM OF γ‐AMINOBUTYRIC ACID IN RAT BRAIN , 1969, Journal of neurochemistry.

[59]  A. Horita,et al.  The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--I. Studies in vitro. , 1969, Biochemical pharmacology.

[60]  Shuting Lin,et al.  Gamma-aminobutyric acid transporter 1 negatively regulates T cell-mediated immune responses and ameliorates autoimmune inflammation in the CNS. , 2008, Journal of immunology.

[61]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[62]  F. Vaccarino,et al.  Analysis of amino acids and catecholamines, 5-hydroxytryptamine and their metabolites in brain areas in the rat using in vivo microdialysis. , 2001, Methods.

[63]  E. M. Barnes,et al.  Use-dependent regulation of GABAA receptors. , 1996, International review of neurobiology.

[64]  T. Paslawski,et al.  Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain. , 1995, Progress in brain research.

[65]  G. Baker,et al.  Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA). , 1991, Journal of affective disorders.